Answers are grounded in this paper and cite their sources.
CRP concentration was identified as a novel marker associated with CsA pharmacokinetics, which should be considered when determining the appropriate dosage of CsA in allo-HSCT recipients.
No takes yet. Share an insight, caveat, or question.
Ling et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: